Doctors urged to discuss use of breast cancer prevention drugs

07/9/2013 | HealthDay News

The American Society of Clinical Oncology issued new practice guidelines urging physicians to discuss the use of so-called chemopreventive drugs with their female patients at high risk of breast cancer. Doctors should explain the risks and benefits of tamoxifen for high-risk premenopausal women, and those of tamoxifen, raloxifene and exemestane for high-risk postmenopausal women. The recommendations were published in the Journal of Clinical Oncology.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN